CMSCX
Price
$40.52
Change
-$0.76 (-1.84%)
Updated
Jul 13 closing price
Net Assets
3.69B
VSGAX
Price
$122.72
Change
-$1.76 (-1.41%)
Updated
Jul 13 closing price
Net Assets
47.01B
Interact to see
Advertisement

CMSCX vs VSGAX

CMSCX vs VSGAX Comparison Chart in %
View a ticker or compare two or three
VS
CMSCX vs. VSGAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMSCX is a Hold and VSGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 47B vs. CMSCX (3.69B). VSGAX pays higher dividends than CMSCX: VSGAX (0.41) vs CMSCX (0.00). CMSCX was incepted earlier than VSGAX: CMSCX (30 years) vs VSGAX (15 years). CMSCX (0.97) is less costly to investors than VSGAX (0.07). CMSCX is a more actively managed with annual turnover of: 122.00 vs. VSGAX (24.00). CMSCX has a lower initial minimum investment than VSGAX: CMSCX (2000) vs VSGAX (3000). CMSCX annual gain was more profitable for investors over the last year : 41.18 vs. VSGAX (26.87). VSGAX return over 5 years is better than : 27.71 vs. CMSCX (23.70).
CMSCXVSGAXCMSCX / VSGAX
Total Expense Ratio0.970.071,386%
Annual Report Gross Expense Ratio0.970.071,386%
Fund Existence30 years15 years-
Gain YTD24.63817.371142%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets3.69B47B8%
Annual Yield % from dividends0.000.41-
Returns for 1 year41.1826.87153%
Returns for 3 years83.5551.26163%
Returns for 5 years23.7027.7186%
Returns for 10 years131.91181.6073%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POVYX34.78N/A
N/A
Putnam International Equity Y
CIVVX25.02N/A
N/A
Causeway International Value Inv
LSCNX24.00-0.10
-0.41%
Loomis Sayles Small Cap Value N
BGEKX14.35-0.18
-1.24%
Baillie Gifford International Growth K
TSCGX21.66-0.29
-1.32%
Thrivent Small Cap Growth S